GENEVA, July 31 -- D3 BIO (WUXI) CO., LTD. filed a patent application (CN2026/073652) for “SUBSTITUTED PYRIMIDOPYRAN COMPOUNDS AS PAN-KRAS MODULATOR AND USES THEREOF”. With publication no. WO/2026/158289, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 519/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....